4
Changes in Ownership
COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-25-014766
EVP & Chief Commercial Officer sold 16,389 shares at $38.21 ($626,171)
- EVP & Chief Commercial Officer acquired 16,389 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Dreyer Scott · EVP & Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +16,389 | $21.34 | $349,741 | 120,002 | D |
| 2025-08-18 | Sale : show line 2 in the form 10b5-1 | −16,389 | $38.21 | $626,171 | 103,613 | D |
| Open-market sales · 16,389 sh · avg $38.21 · $626,171 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-18 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Purchase) | −16,389 | 0 | D |
Loading xslF345X05/form4.xml…